[1]
|
Stankiewicz, J, Panter, S.S., Neema, M., et al. (2007) Iron in chronic brain disorders: Imaging and neurotherapeutic implications. Neurotherapeutics, 4, 371-386.
doi:10.1016/j.nurt.2007.05.006
|
[2]
|
Perry, G., Nunomura, A., Hirai, K., et al. (2000) Oxidative damage in Alzheimer’s disease: The metabolic dimension. International Journal of Developmental Neuroscience, 18, 417-421.
doi:10.1016/S0736-5748(00)00006-X
|
[3]
|
Nunomura, A., Perry, G., Aliev, G., et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. Journal of Neuropathology & Experimental Neurology, 60, 759-767.
|
[4]
|
Atwood, C.S., Obrenovich, M.E., Liu, T.B., et al. (2003) Amyloid-β: A chameleon walking in two worlds: A review of the trophic and toxic properties of amyloid-β. Brain Research Reviews, 43, 1-16.
doi:10.1016/S0165-0173(03)00174-7
|
[5]
|
Schubert, D. and Chevion, M. (1995) The role of iron in beta amyloid toxicity. Biochemical and Biophysical Research Communications, 216, 702-707.
doi:10.1006/bbrc.1995.2678
|
[6]
|
Siemonsen, S., Finsterbusch, J., Matschke, J., et al. (2008) Age-dependent normal values of T2* and T2' in brain parenchyma. American Journal of Neuroradiology, 29, 950-955. doi:10.3174/ajnr.A0951
|
[7]
|
Peran, P., Hagberg, G., Luccichenti, G., et al. (2007) Voxel-based analysis of R2* maps in the healthy human brain. Journal of Magnetic Resonance Imaging, 26, 1413-1420. doi:10.1002/jmri.21204
|
[8]
|
Jensen, J.H., Szulc, K., Hu, C.X., et al. (2009) Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magnetic Resonance in Medicine, 61, 481-485. doi:10.1002/mrm.21823
|
[9]
|
Bartzokis, G., Tishler, T.A., Lu, P.H., et al. (2007) Brain ferritin iron influence age- and gender-related risks of neurodegeneration. Neurobiology of Aging, 28, 414-423.
doi:10.1016/j.neurobiolaging.2006.02.005
|
[10]
|
Yao, B., Li, T.Q., Van Gelderen, P., et al. (2009) Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage, 44, 1259-1266. doi:10.1016/j.neuroimage.2008.10.029
|
[11]
|
Xu, X.J., Wang, Q.D. and Zhang, M.M. (2008) Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study. Neuroimage, 40, 35-42. doi:10.1016/j.neuroimage.2007.11.017
|
[12]
|
Harder, S.L., Hopp, K.M., Ward, H., et al. (2008) Mineralization of the deep gray matter with age: A retrospective review with susceptibility-weighted MR imaging. American Journal of Neuroradiology, 29, 176-183.
doi:10.3174/ajnr.A0770
|
[13]
|
Haacke, E.M., Cheng, N.Y., House, M.J., et al. (2005) Imaging iron stores in the brain using magnetic resonance imaging. Journal of Magnetic Resonance Imaging, 23, 1-25. doi:10.1016/j.mri.2004.10.001
|
[14]
|
Pfefferbaum, A., Adalsteinsson, E., Rohlfing, T., et al. (2009) MRI estimates of brain iron concentration in normal aging: Comparison of field-dependent (FDRI) and phase(SWI) methods. NeuroImage, 47, 493-500.
doi:10.1016/j.neuroimage.2009.05.006
|
[15]
|
Ogg, R.J., Langston, J.W., Haacke, E.M., et al. (1999) The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Journal of Magnetic Resonance Imaging, 17, 1141-1148.
doi:10.1016/S0730-725X(99)00017-X
|
[16]
|
Haacke, E.M., Xu, Y.B., Cheng, Y.C.N., et al. (2004) Susceptibility weighted imaging (SWI). Magnetic Resonance in Medicine, 52, 612-618. doi:10.1002/mrm.20198
|
[17]
|
McCrea, R.P., Harder, S.L., Martin, M., et al. (2008) A comparison of rapid-scanning X-ray fluorescence mapping and magnetic resonance imaging to localize brain iron distribution. European Journal of Radiology, 68, S109-S113. doi:10.1016/j.ejrad.2008.04.048
|
[18]
|
Haacke, E.M., Ayaz, M., Khan, A., et al. (2007) Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. Journal of Magnetic Resonance Imaging, 26, 256-264. doi:10.1002/jmri.22987
|
[19]
|
Chamberlain, R., Reyes, D., Curran, G.L., et al. (2009) Comparison of amyloid plaque contrast generated by T-2-weighted, T-2(star)-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer’s disease. Magnetic Resonance in Medicine, 61, 1158-1164. doi:10.1002/mrm.21951
|
[20]
|
Meadowcroft, M.D., Connor, J.R., Smith, M.B., et al. (2009) MRI and histological analysis of beta-amyloid plaques in both human Alzheimer’s disease and APP/PS1 transgenic mice. Journal of Magnetic Resonance Imaging, 29, 997-1007. doi:10.1002/jmri.21731
|
[21]
|
Zhu, W.Z., Zhong, W.D., Wang, W., et al. (2009) Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology, 253, 497-504.
doi:10.1148/radiol.2532082324
|
[22]
|
McKhann, G., Drachman, D., Folstein, M., et al. (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology, 34, 939-944.
doi:10.1212/WNL.34.7.939
|
[23]
|
Berg, D. and Youdim, M.B. (2006) Role of iron in neurodegenerative disorders. Topics in Magnetic Resonance Imaging, 17, 5-17.
doi:10.1097/01.rmr.0000245461.90406.ad
|
[24]
|
Good, P.F., Perl, D.P., Bierer, L.M., et al. (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer’s disease: A laser microprobe (LAMMA) study. Annals of Neurology, 31, 286-292.
doi:10.1002/ana.410310310
|
[25]
|
Dedman, D.J., Treffry, A., Candy, J.M., et al. (1992) Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer’s disease and chronic renal-dialysis patients. Biochemical Journal, 287, 509-514.
|
[26]
|
Connor, J.R., Snyder, B.S., Beard, J.L., et al. (1992) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer’s disease. Journal of Neuroscience Research, 31, 327-335.
doi:10.1002/jnr.490310214
|
[27]
|
Loeffler, D.A., Lewitt, P.A., Juneau, P.L., et al. (1996) Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Research, 738, 265-274. doi:10.1016/S0006-8993(96)00782-2
|
[28]
|
Pappolla, M.A., Omar, R.A., Kim, K.S., et al. (1992) Immunohistochemical evidence of antioxidant stress in Alzheimer’s disease. American Journal of Pathology, 140, 621-628.
|
[29]
|
Smith, M.A., Zhu, X.W., Tabaton, M., et al. (2010) Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. Journal of Alzheimer’s Disease, 19, 363-372.
|
[30]
|
Bartzokis, G., Tishler, T.A., Shin, I.S., et al. (2004) Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Annals of the New York Academy of Sciences, 1012, 224-236. doi:10.1196/annals.1306.019
|
[31]
|
Press, D.Z., Casement, M.D., Schenck, J.F., et al. (2004) High field MRI demonstrates increased brain iron in Alzheimer’s disease. Neurobiology of Aging, 25, S378-S379.
doi:10.1016/S0197-4580(04)81240-5
|
[32]
|
Bartzokis, G., Sultzer, D., Cummings, J., et al. (2000) In vivo evaluation of brain iron in Alzheimer Disease using magnetic resonance imaging. Archives of General Psychiatry, 57, 47-53. doi:10.1001/archpsyc.57.1.47
|
[33]
|
Ding, B., Chen, K.M., Ling, H.W., et al. (2009) Correlation of iron in the hippocampus with MMSE in patients with Alzheimer’s disease. Journal of Magnetic Resonance Imaging, 29, 793-798. doi:10.1002/jmri.21730
|
[34]
|
House, M.J., Pierre, T.G.S., and McLean, C. (2008) 1.4T study of proton magnetic relaxation rates, iron concentrations, and plaque burden in Alzheimer’s disease and control postmortem brain tissue. Magnetic Resonance in Medicine, 60, 41-52. doi:10.1002/mrm.21586
|
[35]
|
Haacke, E.M., Miao, Y.W., Liu, M.J., et al. (2010) Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. Journal of Magnetic Resonance Imaging, 32, 561- 576. doi:10.1002/jmri.22293
|
[36]
|
Duyn, J.H., Van Gelderen, P., Li, T.Q., et al. (2007) High-field MRI of brain cortical substructure based on signal phase. Proceedings of the National Academy of Sciences of the United State of America, 104, 11796-11801. doi:10.1073/pnas.0610821104
|
[37]
|
Kirsch, W., McAuley, G., Holshouser, B., et al. (2009) Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. Journal of Alzheimer’s Disease, 17, 599-609.
|
[38]
|
Steffens, D.C., Tupler, L.A., Ranga, K., et al. (1998) Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients. Journal of Psychiatric Research, 83, 95-103.
doi:10.1016/S0925-4927(98)00032-8
|
[39]
|
Visser, P.J., Verhey, F.R.J., Ponds, R.W.H.M., et al. (2000) Distinction between preclinical Alzheimer’s disease and depression. Journal of the American Geriatrics Society, 48, 479-484.
|
[40]
|
Sluimer, J.D., Van der Flier, W.M., Karas, G.B., et al. (2009) Accelerating regional atrophy rates in the progression from normal aging to Alzheimer’s disease. European Radiology, 19, 2826-2833.
doi:10.1007/s00330-009-1512-5
|
[41]
|
Scahill, R.I., Schott, J.M., Stevens, J.M., et al. (2002) Mapping the evolution of regional atrophy in Alzheimer’s disease: Unbiased analysis of fluid-registered serial MRI. Proceedings of the National Academy of Sciences of the United State of America, 99, 4703-4707.
doi:10.1073/pnas.052587399
|